엡스타인-바 바이러스 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "엡스타인-바 바이러스" in Korean language version.

refsWebsite

Global rank Korean rank

17nih.gov

4^th place

16doi.org

2^nd place

3^rd place

4web.archive.org

1^st place

3cdc.gov

218^th place

52^nd place

2archive.org

6^th place

18^th place

1ictvonline.org

5,233^rd place

2,735^th place

1harvard.edu

18^th place

27^th place

1cancerresearchuk.org

8,489^th place

7,818^th place

archive.org

Nussinovitch M, Prais D, Volovitz B, Shapiro R, Amir J (September 2003). “Post-infectious acute cerebellar ataxia in children”. 《Clinical Pediatrics》 42 (7): 581–4. doi:10.1177/000992280304200702. PMID 14552515.
Wang X, Hutt-Fletcher LM (January 1998). “Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect”. 《Journal of Virology》 72 (1): 158–63. doi:10.1128/jvi.72.1.158-163.1998. PMC 109360. PMID 9420211.

cancerresearchuk.org

“Developing a vaccine for the Epstein–Barr Virus could prevent up to 200,000 cancers globally say experts”. 2014년 3월 24일. 2017년 3월 19일에 원본 문서에서 보존된 문서.

cdc.gov

About 90% of adults have antibodies that show that they have a current or past EBV infection. 보관됨 2016-08-08 - 웨이백 머신 National Center for Infectious Diseases
CDC. “Epstein–Barr Virus and Infectious Mononucleosis”. CDC. 2012년 4월 20일에 원본 문서에서 보존된 문서. 2011년 12월 29일에 확인함.
“About Epstein–Barr Virus (EBV)”. Centers for Disease Control and Prevention. 2016년 9월 14일.

doi.org

dx.doi.org

Rezk SA, Zhao X, Weiss LM (September 2018). “Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update”. 《Human Pathology》 79: 18–41. doi:10.1016/j.humpath.2018.05.020. PMID 29885408.
Maeda E, Akahane M, Kiryu S, Kato N, Yoshikawa T, Hayashi N, 외. (January 2009). “Spectrum of Epstein-Barr virus-related diseases: a pictorial review”. 《Japanese Journal of Radiology》 27 (1): 4–19. doi:10.1007/s11604-008-0291-2. PMID 19373526.
Mastria G, Mancini V, Viganò A, Di Piero V (2016). “Alice in Wonderland Syndrome: A Clinical and Pathophysiological Review”. 《BioMed Research International》 2016: 8243145. doi:10.1155/2016/8243145. PMC 5223006. PMID 28116304.
Nussinovitch M, Prais D, Volovitz B, Shapiro R, Amir J (September 2003). “Post-infectious acute cerebellar ataxia in children”. 《Clinical Pediatrics》 42 (7): 581–4. doi:10.1177/000992280304200702. PMID 14552515.
Dreyfus DH (December 2011). “Autoimmune disease: A role for new anti-viral therapies?”. 《Autoimmunity Reviews》 11 (2): 88–97. doi:10.1016/j.autrev.2011.08.005. PMID 21871974.
Pender MP (2012). “CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis”. 《Autoimmune Diseases》 2012: 189096. doi:10.1155/2012/189096. PMC 3270541. PMID 22312480.
Ascherio A, Munger KL (September 2010). “Epstein-barr virus infection and multiple sclerosis: a review”. 《Journal of Neuroimmune Pharmacology》 5 (3): 271–7. doi:10.1007/s11481-010-9201-3. PMID 20369303.
Moreno MA, Or-Geva N, Aftab BT, Khanna R, Croze E, Steinman L, Han MH (July 2018). “Molecular signature of Epstein-Barr virus infection in MS brain lesions”. 《Neurology》 5 (4): e466. doi:10.1212/NXI.0000000000000466. PMC 5994704. PMID 29892607.
Hassani A, Corboy JR, Al-Salam S, Khan G (2018). “Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells”. 《PLOS One》 13 (2): e0192109. Bibcode:2018PLoSO..1392109H. doi:10.1371/journal.pone.0192109. PMC 5796799. PMID 29394264.
Toussirot E, Roudier J (October 2008). “Epstein-Barr virus in autoimmune diseases”. 《Best Practice & Research. Clinical Rheumatology》 22 (5): 883–96. doi:10.1016/j.berh.2008.09.007. PMID 19028369.
Khan G, Hashim MJ (2014). “Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010”. 《Infectious Agents and Cancer》 9 (1): 38. doi:10.1186/1750-9378-9-38. PMC 4253616. PMID 25473414.
Amon W, Farrell PJ (November 2004). “Reactivation of Epstein-Barr virus from latency”. 《Reviews in Medical Virology》 15 (3): 149–56. doi:10.1002/rmv.456. PMID 15546128.
Khan G, Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA (August 1996). “Is EBV persistence in vivo a model for B cell homeostasis?”. 《Immunity》 5 (2): 173–9. doi:10.1016/s1074-7613(00)80493-8. PMID 8769480.
Odumade OA, Hogquist KA, Balfour HH (January 2011). “Progress and problems in understanding and managing primary Epstein-Barr virus infections”. 《Clinical Microbiology Reviews》 24 (1): 193–209. doi:10.1128/CMR.00044-10. PMC 3021204. PMID 21233512.
Shannon-Lowe C, Rowe M (February 2014). “Epstein Barr virus entry; kissing and conjugation”. 《Current Opinion in Virology》 4: 78–84. doi:10.1016/j.coviro.2013.12.001. PMID 24553068.
Wang X, Hutt-Fletcher LM (January 1998). “Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect”. 《Journal of Virology》 72 (1): 158–63. doi:10.1128/jvi.72.1.158-163.1998. PMC 109360. PMID 9420211.

harvard.edu

adsabs.harvard.edu

Hassani A, Corboy JR, Al-Salam S, Khan G (2018). “Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells”. 《PLOS One》 13 (2): e0192109. Bibcode:2018PLoSO..1392109H. doi:10.1371/journal.pone.0192109. PMC 5796799. PMID 29394264.

ictvonline.org

talk.ictvonline.org

“ICTV Taxonomy history: Human gammaherpesvirus 4”. 《International Committee on Taxonomy of Viruses (ICTV)》. 2019년 1월 11일에 원본 문서에서 보존된 문서. 2019년 1월 10일에 확인함.

nih.gov

ncbi.nlm.nih.gov

Rezk SA, Zhao X, Weiss LM (September 2018). “Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update”. 《Human Pathology》 79: 18–41. doi:10.1016/j.humpath.2018.05.020. PMID 29885408.
Maeda E, Akahane M, Kiryu S, Kato N, Yoshikawa T, Hayashi N, 외. (January 2009). “Spectrum of Epstein-Barr virus-related diseases: a pictorial review”. 《Japanese Journal of Radiology》 27 (1): 4–19. doi:10.1007/s11604-008-0291-2. PMID 19373526.
Cherry-Peppers G, Daniels CO, Meeks V, Sanders CF, Reznik D (February 2003). “Oral manifestations in the era of HAART”. 《Journal of the National Medical Association》 95 (2 Suppl 2): 21S–32S. PMC 2568277. PMID 12656429.
Mastria G, Mancini V, Viganò A, Di Piero V (2016). “Alice in Wonderland Syndrome: A Clinical and Pathophysiological Review”. 《BioMed Research International》 2016: 8243145. doi:10.1155/2016/8243145. PMC 5223006. PMID 28116304.
Nussinovitch M, Prais D, Volovitz B, Shapiro R, Amir J (September 2003). “Post-infectious acute cerebellar ataxia in children”. 《Clinical Pediatrics》 42 (7): 581–4. doi:10.1177/000992280304200702. PMID 14552515.
Dreyfus DH (December 2011). “Autoimmune disease: A role for new anti-viral therapies?”. 《Autoimmunity Reviews》 11 (2): 88–97. doi:10.1016/j.autrev.2011.08.005. PMID 21871974.
Pender MP (2012). “CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis”. 《Autoimmune Diseases》 2012: 189096. doi:10.1155/2012/189096. PMC 3270541. PMID 22312480.
Ascherio A, Munger KL (September 2010). “Epstein-barr virus infection and multiple sclerosis: a review”. 《Journal of Neuroimmune Pharmacology》 5 (3): 271–7. doi:10.1007/s11481-010-9201-3. PMID 20369303.
Moreno MA, Or-Geva N, Aftab BT, Khanna R, Croze E, Steinman L, Han MH (July 2018). “Molecular signature of Epstein-Barr virus infection in MS brain lesions”. 《Neurology》 5 (4): e466. doi:10.1212/NXI.0000000000000466. PMC 5994704. PMID 29892607.
Hassani A, Corboy JR, Al-Salam S, Khan G (2018). “Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells”. 《PLOS One》 13 (2): e0192109. Bibcode:2018PLoSO..1392109H. doi:10.1371/journal.pone.0192109. PMC 5796799. PMID 29394264.
Toussirot E, Roudier J (October 2008). “Epstein-Barr virus in autoimmune diseases”. 《Best Practice & Research. Clinical Rheumatology》 22 (5): 883–96. doi:10.1016/j.berh.2008.09.007. PMID 19028369.
Khan G, Hashim MJ (2014). “Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010”. 《Infectious Agents and Cancer》 9 (1): 38. doi:10.1186/1750-9378-9-38. PMC 4253616. PMID 25473414.
Amon W, Farrell PJ (November 2004). “Reactivation of Epstein-Barr virus from latency”. 《Reviews in Medical Virology》 15 (3): 149–56. doi:10.1002/rmv.456. PMID 15546128.
Khan G, Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA (August 1996). “Is EBV persistence in vivo a model for B cell homeostasis?”. 《Immunity》 5 (2): 173–9. doi:10.1016/s1074-7613(00)80493-8. PMID 8769480.
Odumade OA, Hogquist KA, Balfour HH (January 2011). “Progress and problems in understanding and managing primary Epstein-Barr virus infections”. 《Clinical Microbiology Reviews》 24 (1): 193–209. doi:10.1128/CMR.00044-10. PMC 3021204. PMID 21233512.
Shannon-Lowe C, Rowe M (February 2014). “Epstein Barr virus entry; kissing and conjugation”. 《Current Opinion in Virology》 4: 78–84. doi:10.1016/j.coviro.2013.12.001. PMID 24553068.
Wang X, Hutt-Fletcher LM (January 1998). “Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect”. 《Journal of Virology》 72 (1): 158–63. doi:10.1128/jvi.72.1.158-163.1998. PMC 109360. PMID 9420211.

web.archive.org

“ICTV Taxonomy history: Human gammaherpesvirus 4”. 《International Committee on Taxonomy of Viruses (ICTV)》. 2019년 1월 11일에 원본 문서에서 보존된 문서. 2019년 1월 10일에 확인함.
“Developing a vaccine for the Epstein–Barr Virus could prevent up to 200,000 cancers globally say experts”. 2014년 3월 24일. 2017년 3월 19일에 원본 문서에서 보존된 문서.
About 90% of adults have antibodies that show that they have a current or past EBV infection. 보관됨 2016-08-08 - 웨이백 머신 National Center for Infectious Diseases
CDC. “Epstein–Barr Virus and Infectious Mononucleosis”. CDC. 2012년 4월 20일에 원본 문서에서 보존된 문서. 2011년 12월 29일에 확인함.